Utility of Transcutaneous Bilirubin Measurement in Predicting Early Need for Phototherapy in Newborns with Positive Direct Antiglobulin Testing

Timothy Porter, Brigham and Women's Hospital, Arlington, MA, United States; Hailey M. Foster, Brigham and Women's Hospital, Clearwater, FL, United States; Amanda C. Rivera-Morales, Brigham and Women's Hospital, Guaynabo, PR, N/A, Puerto Rico; Sara Cherkerzian, Brigham and Women's Hospital, Boston, MA, United States; Kathryn Dee MacMillan, Children's Hospital at Dartmouth-Hitchcock, Lebanon, NH, United States